Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

124.57
Delayed Data
As of 3:53pm ET
 -0.295 / -0.24%
Today’s Change
94.42
Today|||52-Week Range
127.64
+7.62%
Year-to-Date
Will These Three Drugs Continue Driving Celgene's Top-Line Growth?
9:49am / Zacks.com - Paid Partner Content
Biotech Bull Making a Comeback
Mar 21 / Zacks.com - Paid Partner Content
Stock Market News for March 27, 2017
Mar 27 / Zacks.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Why Concert Pharmaceuticals Is Music to Investors' Ears
Mar 26 / TheStreet.com - Paid Partner Content
Why Biotech Stock Gilead (GILD) Could Be a Value Trap
Mar 20 / Zacks.com - Paid Partner Content
Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valean...
Mar 22 / Zacks.com - Paid Partner Content
Amgen's Repatha Meets Primary Endpoint in Phase III Study
Mar 14 / Zacks.com - Paid Partner Content
Infinity Pharma Focuses on Cancer Drug: Competition Looms
Mar 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close124.86
Today’s open124.61
Day’s range123.76 - 125.45
Volume2,602,894
Average volume (3 months)4,230,627
Market cap$97.1B
Dividend yield--
Data as of 3:53pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+21.50%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+22.70%
P/E ratio50.0
Price/Sales8.51
Price/Book14.73

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.53+0.63%
BMYBristol-Myers Squibb+0.11+0.19%
GSKGlaxoSmithKline-0.28-0.66%
ABBVAbbVie-0.13-0.19%
Data as of 3:53pm ET, 03/28/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$1.63
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts


Search for Jobs